Advanced Biomedical Technologies Inc
Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for… Read more
Advanced Biomedical Technologies Inc (ABMT) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of July 2022: 0.020x
Based on the latest financial reports, Advanced Biomedical Technologies Inc (ABMT) has a cash flow conversion efficiency ratio of 0.020x as of July 2022.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-170.31K) by net assets ($-8.32 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Advanced Biomedical Technologies Inc - Cash Flow Conversion Efficiency Trend (2006–2022)
This chart illustrates how Advanced Biomedical Technologies Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Advanced Biomedical Technologies Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Advanced Biomedical Technologies Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Vitruvia Medical AG
MU:991
|
N/A |
|
Kairous Acquisition Corp. Limited Warrants
NASDAQ:KACLW
|
-0.009x |
|
Agriculture Printing and Packaging JSC
VN:INN
|
N/A |
|
Colombo Investment Trust PLC
CM:CITN0000
|
N/A |
|
GreenBank Capital Inc
PINK:GRNBF
|
-0.001x |
|
OPCT3F
SA:OPCT3F
|
N/A |
|
BIOSTIME INTL
BE:8BI
|
N/A |
|
HAPV3F
SA:HAPV3F
|
N/A |
Annual Cash Flow Conversion Efficiency for Advanced Biomedical Technologies Inc (2006–2022)
The table below shows the annual cash flow conversion efficiency of Advanced Biomedical Technologies Inc from 2006 to 2022.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-10-31 | $-7.94 Million | $-734.53K | 0.093x | -8.24% |
| 2021-10-31 | $-8.38 Million | $-845.61K | 0.101x | +215.44% |
| 2020-10-31 | $-7.40 Million | $646.66K | -0.087x | -176.22% |
| 2019-10-31 | $-6.48 Million | $-742.53K | 0.115x | -22.63% |
| 2018-10-31 | $-5.62 Million | $-832.42K | 0.148x | +32.68% |
| 2017-10-31 | $-5.00 Million | $-557.71K | 0.112x | +31.05% |
| 2016-10-31 | $-4.36 Million | $-371.65K | 0.085x | -53.67% |
| 2015-10-31 | $-4.46 Million | $-820.39K | 0.184x | -6.14% |
| 2014-10-31 | $-3.74 Million | $-732.42K | 0.196x | -4.97% |
| 2013-10-31 | $-2.93 Million | $-604.97K | 0.206x | -24.74% |
| 2012-10-31 | $-2.23 Million | $-609.84K | 0.274x | +101.91% |
| 2011-10-31 | $-1.56 Million | $-212.03K | 0.136x | -50.49% |
| 2010-10-31 | $-1.49 Million | $-408.41K | 0.274x | -29.46% |
| 2009-10-31 | $-1.26 Million | $-490.48K | 0.388x | +71.46% |
| 2008-10-31 | $-750.42K | $-170.00K | 0.227x | +103.80% |
| 2007-10-31 | $7.10K | $-42.36K | -5.968x | -13554.51% |
| 2006-10-31 | $-12.58K | $550.00 | -0.044x | -- |